Interview: Ufuk Kumrulu – Chairman, Polifarma – Turkey
Polifarma is Turkey’s largest producer of basic parenteral IV solutions with a 41 percent market share the country and growing exports across the region. According to the Chairman and CEO…
Polifarma is the leading producer of basic IV and parenteral solutions in Turkey, with a 30 000 square meter production facility in Tekirdag that produces solutions in a variety of forms and volumes, including polypropylene (PP) bags, PP bottles, polyvinyl chloride (PVC) bags, and glass bottles. Starting in 2011, Polifarma began to expand their business into hospital IV soultions as well, and leads the Turkish market in a certain categories with premixed hospital IV solution products, and has developed an aseptic production line to support their growth in the hospital solutions market.
Contact Details
Capital Tower
Halkali Merkez Mah. Basin Ekspres Yolu No: 9 Kat: 6
P.C.: 34259 Halkali/Istanbul/Turkey
Phone: +90 (212) 481 00 13-17
Fax: +90 (212) 481 00 73
info@polifarma.com.tr
export@polifarma.com.tr
Polifarma is Turkey’s largest producer of basic parenteral IV solutions with a 41 percent market share the country and growing exports across the region. According to the Chairman and CEO…
Renan Ozyerli of MSD Turkey provides insights into the transformation of Turkey’s healthcare ecosystem over the past decade, highlighting how MSD works hand-in-hand with the government to broaden access to…
Raphaël Esposito, director of the French Chamber of Commerce in Turkey, sheds light on issues ranging from venture partnerships to cultural specificities, while underlining Turkey’s capacity to respond to the…
Asli Özelli, newly appointed executive director of AmCham Turkey, discusses the economic landscape of Turkey and its attractiveness for American companies, in addition to highlighting her priorities in her new…
Hande Demirdere, general manager of Pierre Fabre Pharma in Turkey, sheds light on the affiliate’s impressive 93 percent growth in 2017 while highlighting where to target development opportunities in the…
Selim Giray, the recently appointed VP and general manager of GSK Turkey, provides insights into the company’s eye-catching footprint and commitment to Turkey, his ambition to integrate into the market’s…
In Summer 2018, we spoke to Adriano Antonio Treve, then general manager of Roche Turkey, now Area Head Central Eastern Europe, Turkey, Russia, Central Asia, Iran, Pakistan & Indian Subcontinent.…
Elif Aral, country manager of Pfizer Turkey, stresses that Turkey will continue to be perceived as essential and important, where healthcare is a top priority with its young but aging…
Mustafa Kemal Erol , president of the Turkish Society of Cardiology, introduces one of the oldest and largest societies in the country divulges their best collaborations with the Ministry of…
Abdi İbrahim Otsuka, the Turkish-Japanese hybrid pharmaceutical company, celebrated their five-year anniversary just last year and have ambitions to become the Number One Japanese company in Turkey. Elif Elkin, in…
Mark Dekker, general manager of Astellas in Turkey, describes the ever-increasing commitment of the company to Turkey and the recent doubling of Astellas’ portfolio in the country, while pinpointing the…
Mahmut Gümüş, president of the Turkish Society of Medical Oncology, paints a descriptive picture of the oncology situation in the country, with the looming epidemiological shift set to transform the…
Hakan Koçak, CEO–general manager of Koçak Farma, a company with 47 years in the pharmaceutical industry and the biggest production facility in Turkey, gives a thorough insight into Koçak Farma’s…
See our Cookie Privacy Policy Here
